CD274 and osteosarcoma: Furthermore, preclinical studies on murine osteosarcoma models demonstrated that combination of sunitinib with PD-L1 blockade reduced the expression of PD-L1 by suppressing STAT3 activation, and thus inhibiting lung metastases, tumor growth which in turn improved survival 168.